News
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...
Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...
We really think of it as hopefully being a key new tool in forecasting and predicting risk for diseases, especially Alzheimer ...
As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...
Scientists found that brain cells can tap a hidden sugar stash to clean up the toxic proteins behind Alzheimer’s. By kick-starting an enzyme called GlyP, they reroute stored sugar into a protective ...
Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...
According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...
1d
News-Medical.Net on MSNClinical trial examines whether Ambroxol can slow dementia in people with Parkinson'sResearchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results